CathWorks
CathWorks is a medical technology company specializing in cardiac care solutions. They offer the CathWorks FFRangio® System, which utilizes artificial intelligence to provide non-invasive physiological assessments from angiograms. Their primary customers are hospitals and healthcare providers seeking to enhance diagnostic accuracy and improve patient outcomes in cardiology. The company operates in the healthcare technology sector, focusing on innovative solutions for cardiac diagnostics.
Headcount
Website visitors
Workforce
Headcount by location
- United States66%
- Israel34%
Split by department
- Engineering & R&D42%
- Healthcare14%
- Sales13%
- Founder, Owner & Executive7.2%
- Other23%
Seniority distribution
- Less than 5 years65%
- 5 to 10 years26%
- 10 to 20 years5.8%
- 20 to 30 years1.4%
- 30 years and more1.4%
Funding
Raised to date
- 20 Apr 2026Company Acquisition$585.0MMedtronic
- 12 Jul 2022Series Other$75.0MMedtronic
4 earlier rounds, with their terms and sources.
Investors
aVenture (Techstars '23)aVenture is a venture capital research platform that provides detailed analysis and data on startups and venture capital investments. It serves investors and organizations seeking insights to inform their investment decisions. The platform operates146United States
MedtronicMedtronic is a global medical‑technology company that designs, manufactures, and sells advanced medical devices across cardiovascular, medical‑surgical, neuroscience, and diabetes portfolios. It serves patients, clinicians, hospitals, and health136United States
Pontifax Venture CapitalPontifax Venture Capital is a venture capital firm specializing in life sciences. The company invests in transformative healthcare technologies and manages a portfolio of companies developing innovative solutions. Their customers are primarily73Israel
TriventuresTriventures is a venture capital firm specializing in investments in early-stage companies across healthcare, technology, and fintech sectors. They leverage their global presence and strategic partnerships to provide funding and support to29Israel
Revenue
EBITDA
Revenue source: Modeled estimate
Recent news
- Medtech investment firm NovoMed PARTNERS launches in California.leaves
- Landmark ALL-RISE(R) trial results presented at ACC.26: CathWorks FFRangio demonstrates similar clinical outcomes to invasive wire-based physiology assessment.attends event
- CathWorks FFRangio: proven outcomes without compromise or complications (TCT 2025, san francisco, CA).attends event
- CathWorks announces key events for TCT 2025.attends event
People
How the team has changed month by month — joiners, leavers and where the hiring is going
Connections
Who at your firm already knows someone here, and how warm the path is
The full CathWorks profile lives in Inven.
Your competitors are already on Inven
See how Inven turns hours of manual research into a single, structured workflow.